Fanconi Anemia, Complementation Group L (FANCL) (Middle Region) Peptide
FANCL
Reactivity: Human
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN976692
Quick Overview for Fanconi Anemia, Complementation Group L (FANCL) (Middle Region) Peptide (ABIN976692)
Target
FANCL
(Fanconi Anemia, Complementation Group L (FANCL))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-FANCL antibody (Catalog #: ARP56321_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
-
Background
-
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FAN
Alias Symbols: FAAP43, FLJ10335, PHF9, POG
Protein Interaction Partner: ACVR1,BMPR1B,C17orf70,GGN,HES1,TGFBR1,FANCA,FANCM,YDL160C-A,YOL086W-A
Protein Size: 380 -
Molecular Weight
- 42 kDa
-
Gene ID
- 55120
-
NCBI Accession
- NM_001114636, NP_001108108
-
UniProt
- Q9NW38
Target
-
You are here:
